{"id":13798,"date":"2024-09-03T10:38:11","date_gmt":"2024-09-03T17:38:11","guid":{"rendered":"https:\/\/depts.washington.edu\/diabetes\/?p=13798"},"modified":"2024-09-03T10:38:11","modified_gmt":"2024-09-03T17:38:11","slug":"lilly-to-sell-lower-cost-tirzepatide-vials","status":"publish","type":"post","link":"https:\/\/depts.washington.edu\/diabetes\/lilly-to-sell-lower-cost-tirzepatide-vials\/","title":{"rendered":"Lilly to sell lower-cost tirzepatide vials"},"content":{"rendered":"<section class=\"kc-elm kc-css-955414 kc_row\"><div class=\"kc-row-container  kc-container\"><div class=\"kc-wrap-columns\"><div class=\"kc-elm kc-css-802149 kc_col-sm-12 kc_column kc_col-sm-12\"><div class=\"kc-col-container\"><div class=\"kc-elm kc-css-9558 kc_text_block\"><p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">Eli Lilly and Co. said that to address demand issues and increase access to its weight-loss drug tirzepatide, it will sell single-dose vials of the prescription medication in the US at prices significantly lower than what it charges for its auto-injector pens. Patients will be able to get the Zepbound vials only by paying out of pocket at the company&#8217;s LillyDirect website.<\/span><\/span><\/p>\n<p class=\"MsoNormal\" style=\"line-height: 18.75pt;\"><span style=\"color: #999999; font-family: Helvetica, sans-serif;\"><span style=\"font-size: 15.3333px;\">\u00a0Full Story: <a href=\"https:\/\/www.healthday.com\/health-news\/weight-loss\/weight-loss-drug-zepbound-now-in-single-dose-vials-at-half-the-price\">HealthDay News<\/a> (8\/27),\u00a0 <a href=\"https:\/\/www.medscape.com\/s\/viewarticle\/lilly-launches-single-dose-vials-zepbound-weight-loss-expand-2024a1000fmk\">Medscape<\/a> (8\/27)\u00a0\u00a0<\/span><\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<p><span style=\"font-style: inherit;\">\u00a0<\/span><\/p>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<div>\u00a0<\/div>\n<\/div><\/div><\/div><\/div><\/div><\/section><!-- \/wp:post-content -->","protected":false},"excerpt":{"rendered":"","protected":false},"author":3,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false,"footnotes":""},"categories":[17],"tags":[],"class_list":["post-13798","post","type-post","status-publish","format-standard","hentry","category-diabetes-related-news"],"_links":{"self":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/comments?post=13798"}],"version-history":[{"count":1,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13798\/revisions"}],"predecessor-version":[{"id":13799,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/posts\/13798\/revisions\/13799"}],"wp:attachment":[{"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/media?parent=13798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/categories?post=13798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/depts.washington.edu\/diabetes\/wp-json\/wp\/v2\/tags?post=13798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}